FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a method of controlling pain and reducing intraocular pressure involving the administration of a compound of formula 
, wherein X represents O, S or NH; Ra, Rb, Rc and Rd are independently specified in H, methyl, ethyl, C3 alkyl and C4 alkyl, F, Cl Br, -CH2OH, -CH2NH2, -CHNH(C1-4 alkyl), -CN(C1-4 alkyl)2, -CH2CN and CF3; and Re represents H or C1-4 alkyl. Also, the invention refers to specific indane derivatives.
EFFECT: there are presented new methods of using the known compounds, as well as there are produced new indane derivatives effective in controlling pain and reducing intraocular pressure.
16 cl, 1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONDENSED CARBOCYCLE SUBSTITUTED DIHYDROIMIDAZOLE DERIVATIVES USED FOR PAIN CONTROL OR MANAGEMENT OF GLAUCOMA-LIKE CONDITIONS | 2008 |
|
RU2481335C2 |
| CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
| COMPOUNDS OF ((PHENYL)IMIDAZOLYL)METHYL-HETEROARYL, USE THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS, AND KIT CONTAINING SUCH COMPOSITION | 2008 |
|
RU2478631C2 |
| HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR USE | 2012 |
|
RU2648997C2 |
| AMINOINDANE COMPOUNDS AND USE THEREOF IN TREATING PAIN | 2012 |
|
RU2612959C2 |
| FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679914C9 |
| COMPOUNDS FOR THE TREATMENT OF CERTAIN LEUKOSIS | 2019 |
|
RU2804709C2 |
| DIPHENYL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT | 1997 |
|
RU2175319C2 |
| N2-(2-PHENYL)-PYRIDO[3,4-D]PYRIMIDINE-2,8-DIAMINE DERIVATIVES AND USE THEREOF AS MPS1 INHIBITOR | 2015 |
|
RU2693460C2 |
| PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | 2006 |
|
RU2420519C2 |
